SynBioBeta Speaker
Magdalena Chullmir
Levya
CEO
Magdalena Chullmir is the CEO and co-founder of Levya, a biotech company developing fats and oils with wild yeasts from Latin America. She leads strategy, commercialization, and investor relations with a focus on translating scientific innovation into products that solve real market challenges.Trained as a chemical engineer, Magdalena brings experience in the food industry, quality systems, and cross-industry operations, which gives her a practical understanding of how ingredients are evaluated, adopted, and scaled. Her background has shaped a strong commercial lens on customer pain points, especially around ingredient performance, sourcing volatility, traceability, and growing sustainability demands.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Magdalena
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
